Casetta G - Search Results

1

Enhanced urinary gelatinase activities (matrix metalloproteinases 2 and 9) are associated with early-stage bladder carcinoma: a comparison with clinically used tumor markers.

Sier CF, Casetta G, Verheijen JH, Tizzani A, Agape V, Kos J, Blasi F, Hanemaaijer R. Sier CF, et al. Among authors: casetta g. Clin Cancer Res. 2000 Jun;6(6):2333-40. Clin Cancer Res. 2000. PMID: 10873084

2

Presence of urokinase-type plasminogen activator receptor in urine of cancer patients and its possible clinical relevance.

Sier CF, Sidenius N, Mariani A, Aletti G, Agape V, Ferrari A, Casetta G, Stephens RW, Brünner N, Blasi F. Sier CF, et al. Among authors: casetta g. Lab Invest. 1999 Jun;79(6):717-22. Lab Invest. 1999. PMID: 10378514

3

Urinary evaluation of tumor-associated antigens in urothelial bladder tumors.

Piana P, Casetta G, Cavallini A, Piantino P, Tizzani A. Piana P, et al. Among authors: casetta g. Prog Clin Biol Res. 1991;370:179-84. Prog Clin Biol Res. 1991. PMID: 1924448 No abstract available.

4

p53 expression compared with other prognostic factors in OMS grade-I stage-Ta transitional cell carcinoma of the bladder.

Casetta G, Gontero P, Russo R, Pacchioni D, Tizzani A. Casetta G, et al. Eur Urol. 1997;32(2):229-36. Eur Urol. 1997. PMID: 9286659

5

Urinary evaluation of tumor-associated antigens in bladder urothelium pathologies.

Tizzani A, Casetta G, Cavallini A, Piana P, Piantino P. Tizzani A, et al. Among authors: casetta g. J Nucl Med Allied Sci. 1990 Oct-Dec;34(4 Suppl):93. J Nucl Med Allied Sci. 1990. PMID: 2092157 No abstract available.

6

CA-50 as tumour marker in transitional bladder carcinoma.

Tizzani A, Casetta G, Piana P, Piantino P. Tizzani A, et al. Among authors: casetta g. Br J Urol. 1989 Jun;63(6):616-8. doi: 10.1111/j.1464-410x.1989.tb05256.x. Br J Urol. 1989. PMID: 2752254

7

Urinary levels of tumour associated antigens (CA 19-9, TPA and CEA) in patients with neoplastic and non-neoplastic urothelial abnormalities.

Casetta G, Piana P, Cavallini A, Vottero M, Tizzani A. Casetta G, et al. Br J Urol. 1993 Jul;72(1):60-4. doi: 10.1111/j.1464-410x.1993.tb06459.x. Br J Urol. 1993. PMID: 8149183

8

Bladder tumor antigen assay as compared to voided urine cytology in the diagnosis of bladder cancer.

Priolo G, Gontero P, Martinasso G, Mengozzi G, Formiconi A, Pelucelli G, Zitella A, Casetta G, Viberti L, Aimo G, Tizzani A. Priolo G, et al. Among authors: casetta g. Clin Chim Acta. 2001 Mar;305(1-2):47-53. doi: 10.1016/s0009-8981(00)00416-2. Clin Chim Acta. 2001. PMID: 11249922

9

Bladder pheochromocytoma: a 3-year follow-up after transurethral resection (TURB).

Baima C, Casetta G, Vella R, Tizzani A. Baima C, et al. Among authors: casetta g. Urol Int. 2000;65(3):176-8. doi: 10.1159/000064868. Urol Int. 2000. PMID: 11054040

10

Progression from superficial to invasive carcinoma of the bladder: genetic evidence of either clonal heterogeneous events.

Volante M, Tizzani A, Casetta G, Zitella A, Pacchioni D, Bussolati G. Volante M, et al. Among authors: casetta g. Hum Pathol. 2001 May;32(5):468-74. doi: 10.1053/hupa.2001.24330. Hum Pathol. 2001. PMID: 11381363

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

90 results

Search Page

Filters